Literature DB >> 9854095

Determination of trimethoprim-sulfamethoxazole resistance in Streptococcus pneumoniae by using the E test with Mueller-Hinton agar supplemented with sheep or horse blood may be unreliable. The Pneumococcal Study Group.

M Lovgren1, L Dell'Acqua, R Palacio, G Echániz-Aviles, A Soto-Noguerón, E Castañeda, C I Agudelo, I Heitmann, M C Brandileone, R C Zanella, A Rossi, J Pace, J A Talbot.   

Abstract

An international, multicenter study compared trimethoprim-sulfamethoxazole MICs for 743 Streptococcus pneumoniae isolates (107 to 244 isolates per country) by E test, using Mueller-Hinton agar supplemented with 5% defibrinated horse blood or 5% defibrinated sheep blood, with MICs determined by the National Committee for Clinical Laboratory Standards broth microdilution reference method. Agreement within 1 log2 dilution and minor error rates were 69.3 and 15.5%, respectively, on sheep blood-supplemented agar and 76.9 and 13.6%, respectively, with horse blood as the supplement. Significant interlaboratory variability was observed. E test may not be a reliable method for determining the resistance of pneumococci to trimethoprim-sulfamethoxazole.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9854095      PMCID: PMC84212     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

1.  Evaluation of commercial methods for determining antimicrobial susceptibility of Streptococcus pneumoniae.

Authors:  F C Tenover; C N Baker; J M Swenson
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

Review 2.  Pan American Health Organization epidemiological surveillance network for Streptococcus pneumoniae.

Authors:  J L di Fabio; A Homma; C de Quadros
Journal:  Microb Drug Resist       Date:  1997       Impact factor: 3.431

3.  Capsular type distribution and susceptibility to antibiotics of Streptococcus pneumoniae clinical strains isolated from Uruguayan children with systemic infections. Pneumococcus Study Group.

Authors:  M Hortal; G Algorta; I Bianchi; G Borthagaray; I Cestau; T Camou; M Castro; M de los Santos; R Diez; L Dell'Acqua; A Galiana; A Giordano; P Giordano; G Lopez-Ghemi; N Milanese; C Mogdasy; R Palacio; W Pedreira; A Pisano; L Pivel
Journal:  Microb Drug Resist       Date:  1997       Impact factor: 3.431

4.  Invasive Streptococcus pneumoniae infections: serotype distribution and antimicrobial resistance in Canada, 1992-1995.

Authors:  M Lovgren; J S Spika; J A Talbot
Journal:  CMAJ       Date:  1998-02-10       Impact factor: 8.262

5.  Canadian national survey of prevalence of antimicrobial resistance among clinical isolates of Streptococcus pneumoniae. Canadian Bacterial Surveillance Network.

Authors:  A E Simor; M Louie; D E Low
Journal:  Antimicrob Agents Chemother       Date:  1996-09       Impact factor: 5.191

6.  Interpretive criteria and quality control parameters for testing of susceptibilities of Haemophilus influenzae and Streptococcus pneumoniae to trimethoprim and trimethoprim-sulfamethoxazole. The Antimicrobial Susceptibility Testing OC Group.

Authors:  P C Fuchs; A L Barry; S D Brown
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

7.  The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: an update from the Centers for Disease Control and Prevention's Pneumococcal Sentinel Surveillance System.

Authors:  J C Butler; J Hofmann; M S Cetron; J A Elliott; R R Facklam; R F Breiman
Journal:  J Infect Dis       Date:  1996-11       Impact factor: 5.226

8.  Distribution of serotypes and antimicrobial resistance of Streptococcus pneumoniae strains isolated in Brazil from 1988 to 1992.

Authors:  J F Sessegolo; A S Levin; C E Levy; M Asensi; R R Facklam; L M Teixeira
Journal:  J Clin Microbiol       Date:  1994-04       Impact factor: 5.948

9.  Emergence of drug-resistant pneumococcal infections in the United States.

Authors:  R F Breiman; J C Butler; F C Tenover; J A Elliott; R R Facklam
Journal:  JAMA       Date:  1994-06-15       Impact factor: 56.272

10.  Quantitative antimicrobial susceptibility testing of Haemophilus influenzae and Streptococcus pneumoniae by using the E-test.

Authors:  J H Jorgensen; A W Howell; L A Maher
Journal:  J Clin Microbiol       Date:  1991-01       Impact factor: 5.948

View more
  2 in total

1.  Development of a Broth Microdilution Method for Exebacase Susceptibility Testing.

Authors:  Jun T Oh; Jane E Ambler; Cara Cassino; Raymond Schuch
Journal:  Antimicrob Agents Chemother       Date:  2021-06-17       Impact factor: 5.191

2.  A Solution to Antifolate Resistance in Group B Streptococcus: Untargeted Metabolomics Identifies Human Milk Oligosaccharide-Induced Perturbations That Result in Potentiation of Trimethoprim.

Authors:  Schuyler A Chambers; Rebecca E Moore; Kelly M Craft; Harrison C Thomas; Rishub Das; Shannon D Manning; Simona G Codreanu; Stacy D Sherrod; David M Aronoff; John A McLean; Jennifer A Gaddy; Steven D Townsend
Journal:  mBio       Date:  2020-03-17       Impact factor: 7.867

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.